1364572-05-3

Basic information

• Product Name: 4-(benzyloxy)-2-bromo-1-fluorobenzene
• Synonyms: 4-(benzyloxy)-2-bromo-1-fluorobenzene
• CAS NO: 1364572-05-3
• Molecular Weight: 0
• Mol File: 1364572-05-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(benzyloxy)-2-bromo-1-fluorobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(benzyloxy)-2-bromo-1-fluorobenzene(1364572-05-3)
• EPA Substance Registry System: 4-(benzyloxy)-2-bromo-1-fluorobenzene(1364572-05-3)

Safety Data

• Hazardous Substances Data: 1364572-05-3(Hazardous Substances Data)

Downstream Products

• 1372147-86-8 benzyl 5-(benzyloxy)-2',3'-dihydro-1'H,2H-spiro[1-benzofuran-3,4'-pyridine]-1'-carboxylate 
• 1372147-76-6 benzyl 4-[4-(benzyloxy)-2-bromophenoxymethyl]-1,2,3,6-tetrahydropyridine-1-carboxylate 
• 1372147-69-7 1-benzyl-4-[4-(benzyloxy)-2-bromophenoxymethyl]-1,2,3,6-tetrahydropyridine 
• 1372147-63-1 1-benzyl-4-[4-(benzyloxy)-2-bromophenoxymethyl]pyridinium bromide 

Relevant articles and documents

2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists

Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein R is R1, R2, R3, R4 and R5 are H, alkyl or alkoxyalkyl; R6 is H, alkyl, hydroxyalkyl or —CH2F; R7, R8 and R9 are H, alkyl, alkoxy, alkylthio, alkoxyalkyl, halo or —CF3; and Z is optionally substituted aryl, heteroaryl or heteroaryl-alkyl are disclosed. Also disclosed is the use of compounds of formula I in the treatment of central nervous system diseases, in particular Parkinson's disease, alone or in combination with other agents for treating Parkinson's disease, and pharmaceutical compositions comprising them.